In-Depth Research on Weigao Group, Xinhua Medical, and Kangbei Medical: Riding the Wave of Innovation in Blood Purification Equipment

Recently, Professor Wang Jiusheng, Executive Vice Chairman and Secretary-General of the Kidney Disease Dialysis Professional Committee of the Chinese Non-Public Medical Institutions Association, led a team to conduct in-depth visits to three companies—Weigao Blood Purification Group, Xinhua Medical’s Blood Purification Division, and Kangbei Medical—from July 12 to July 14. The delegation also included Wang Xin, Senior Economist at Shengyi Hemodialysis Center, and Fu Jing, Researcher at VCBeat Eggshell Research Institute. During these visits, the team gained comprehensive insights into the technical capabilities and innovative achievements of these three enterprises in the field of blood purification, providing valuable data and perspectives for the preparation of the “2023 Report on Innovative Development of Blood Purification Equipment.”

As a prominent leader in the field of blood purification, Weigao operates an advanced manufacturing facility for hemodialysis consumables and equipment in Weihai City. Upon visiting the factory, the team was impressed by its scale and highly efficient production lines. State-of-the-art equipment and a skilled technical team ensure exceptional product quality. Weigao not only possesses independently developed technologies but also maintains close collaborations with multiple research institutions, pooling the expertise of numerous industry elites.

Weigao has long been a pioneer in the field of blood purification equipment. During an interview on July 13, the research team engaged in in-depth discussions with Weigao’s R&D team specializing in blood purification devices. Xin Huijun, General Manager of Weigao Medical Holdings, provided a detailed overview of the latest technological innovations in hemodialysis and measures taken to improve equipment performance. Meanwhile, Weigao is committed to enhancing the intelligence level of its dialysis machines by strengthening remote monitoring and data analytics capabilities, thereby enabling more personalized treatment plans. Notably, Weigao has formed a strategic partnership with Nikkiso, a renowned Japanese medical device manufacturer, to jointly advance the research, development, and innovation of blood purification equipment. This collaboration has introduced advanced technologies and concepts to Weigao, helping it maintain a leading position in the blood purification equipment sector.

Xinhua Medical, established before the founding of the People's Republic of China, is a long-standing state-owned enterprise specializing in the research and development, manufacturing, and sales of medical devices and pharmaceutical equipment. It boasts modern production lines and a highly efficient team in Zibo City. During an interview on July 14, the research team gained an in-depth understanding of Xinhua Medical’s comprehensive strengths. The company has actively responded to national policies on medical devices by increasing its investment in technological innovation. In the field of blood purification equipment, Xinhua Medical adheres to craft-oriented innovation, continuously introducing advanced domestic and international technologies, conducting independent R&D, and collaborating with multiple research institutions, thereby establishing a comprehensive system for technological innovation.

In the interview, Wei Baohua, General Manager of the Blood Purification Products Division, provided a detailed introduction to the latest hemodialysis technologies and further analyzed Shinva Medical’s R&D plans and market prospects for innovation in blood purification equipment. Comparative analysis demonstrates that Shinva Medical’s dialysis membranes exhibit significant advantages in biocompatibility, permeability, and anticoagulant properties, earning broad recognition in clinical practice and providing reliable support for hemodialysis treatment. Shinva Medical has secured multiple technical patents, and its dialysis machines are already in use in the domestic market, with gradual expansion into international markets.

Kanbei (Xuejing) Medical is a company specializing in the research, development, and production of hemoperfusion cartridges and blood adsorption materials. Its new manufacturing facility is nearing completion, with an expected annual production capacity of 5 million units. Kanbei Medical boasts a highly skilled technical team that continuously innovates and enhances product performance to meet market demands. The company has secured multiple technical patents in the field of hemoperfusion, thereby strengthening its competitive edge. It strictly adheres to national and industry standards in quality control and has obtained ISO 13485 certification, ensuring that its product quality meets international benchmarks.

Kangbei Medical’s hemoperfusion cartridges have gained widespread popularity in the market, with their high quality and reliability earning the trust of healthcare institutions and patients. The company will continue to increase its investment in research and development and production, constantly optimize product performance, and drive innovation and advancement in blood purification equipment.

Through this in-depth investigation, the research team has gained a more comprehensive understanding of the technological prowess, innovation capabilities, and future development prospects of these three enterprises in the field of blood purification equipment. As leaders in the medical device sector, Weigao, Xinhua Medical, and Kangbei Medical not only represent the development level of China’s blood purification equipment manufacturing industry but also signify the emergence of China’s medical device industry on the global stage.

Looking ahead, they will continue to lead industry development, constantly exploring new technologies and application areas to provide patients with higher-quality, smarter therapeutic devices. At the same time, we also look forward to seeing more Chinese enterprises stand out in the medical device sector, making China’s medical device industry shine even brighter on the international stage.